RET and multiple endocrine neoplasia type 2: Around the same time, the discovery that germline RET mutations cause multiple endocrine neoplasia type 2 (MEN2) [11] and familial medullary thyroid carcinoma (MTC) revolutionized clinical care through genetic screening and prophylactic thyroidectomy.